Becker's Healthcare April 19, 2024
Riz Hatton

Glucagon-like peptide-1 receptor agonists such as Ozempic have the potential to alter the way ASCs go about procedures.

Two big ways these drugs are affecting ASCs are the way they can change the anesthesia process and care coordination.

“Ozempic and other GLP-1 medications have become the hot topic in the surgical world,” Jackie McLaughlin, BSN, RN, manager of surgical services, outpatient infusions and pain clinic at Aspirus Howard Young Medical Center in Woodruff, Wis., told Becker’s. “The American Society of Anesthesiologists recommends that patients on the GLP-1s hold the medication for one week prior to anesthesia. If the patients that are on the GLP-1 medications are not discovered at least eight days prior to the procedure, the rate of cancellations...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: ASC, Provider
ASCs' growing financial storm
The administrative burdens holding back ASC growth
The cost disparity of colonoscopies at ASCs vs. hospitals
Riding the wave of ASC growth — what's next for industry success
St. Tammany Health System to open $75M surgery center

Share This Article